NCT01819883View on ClinicalTrials.gov

Ectopic Lipid Deposition and Insulin Resistance in After Treatment of Acromegaly

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

March 30, 2016

Study Completion Date

March 30, 2016

Conditions
Acromegaly
Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

Ipsen
All Listed Sponsors
collaborator

Ipsen

INDUSTRY

lead

Massachusetts General Hospital

OTHER

NCT01819883 - Ectopic Lipid Deposition and Insulin Resistance in After Treatment of Acromegaly | Biotech Hunter | Biotech Hunter